News 23.09.2025 BOSTON, Massachusetts and ZUERICH, Switzerland – September 22, 2025 (GLOBE NEWSWIRE) – Biognosys, a pioneer in next-generation proteomics services and software, today announced the expansion of its contract research organization (CRO) services to include quantitative biocrates metabolomics and lipidomics. These services will be offered both in Europe as well as...
News 11.09.2025 Urdorf, Zurich — SecureCell has launched the Numero 3 automated sampling system. The system enables laboratories to reduce their manual workload and generate more reliable data. A webinar on October 15 will discuss the advantages of the Numero 3 system. The biotech company SecureCell AG, based in Urdorf, has further developed...
News 10.09.2025 Switzerland, 10 September 2025 – CUTISS, a late-stage clinical TechBio at the forefront of tissue therapeutics and regenerative medicine, has announced the closing of its Series C round for a total of CHF 56M with existing and new investors, bringing total funds raised to more than CHF 125M. The proceeds will...
News 09.09.2025 Topadur Pharma AG today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its investigational therapy TOP-N53 for the treatment of digital ulcersin patients with systemic sclerosis. Systemic sclerosis is a rare, life-threatening autoimmune disease characterized by fibrosis, vascular damage, and chronic digital ulcers that...
News 08.09.2025 InSphero AG, the pioneer in scalable 3D in vitro technologies for drug safety and efficacy testing, announced the appointment of Dr. Werner Lanthaler, Managing Director of Wlanholding GmbH, former Chief Executive Officer of Evotec SE, and former CFO of Intercell AG, to its Board of Directors. Dr. Lanthaler led Evotec for 16 years, during which he guided the...